| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neural Tube Defects | 33 | 2024 | 371 | 2.820 |
Why?
|
| Teratogens | 20 | 2018 | 92 | 2.230 |
Why?
|
| Anticonvulsants | 24 | 2018 | 430 | 1.940 |
Why?
|
| Valproic Acid | 19 | 2018 | 272 | 1.850 |
Why?
|
| Amides | 8 | 2018 | 115 | 1.630 |
Why?
|
| Abnormalities, Drug-Induced | 15 | 2018 | 99 | 1.440 |
Why?
|
| Arsenates | 7 | 2013 | 19 | 1.440 |
Why?
|
| Folic Acid | 14 | 2024 | 369 | 1.360 |
Why?
|
| Teratogenesis | 3 | 2019 | 8 | 1.320 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 3 | 2019 | 105 | 1.010 |
Why?
|
| Spinal Dysraphism | 6 | 2022 | 266 | 0.870 |
Why?
|
| Embryo, Mammalian | 13 | 2024 | 746 | 0.770 |
Why?
|
| Pregnancy | 37 | 2024 | 8130 | 0.770 |
Why?
|
| Neural Tube | 7 | 2024 | 51 | 0.760 |
Why?
|
| Folic Acid Deficiency | 6 | 2024 | 55 | 0.720 |
Why?
|
| Mice | 65 | 2024 | 35600 | 0.690 |
Why?
|
| Sertraline | 1 | 2020 | 42 | 0.690 |
Why?
|
| Receptors, Cell Surface | 12 | 2013 | 904 | 0.680 |
Why?
|
| Pregnancy Complications | 2 | 2015 | 564 | 0.640 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2015 | 263 | 0.590 |
Why?
|
| Environmental Pollutants | 2 | 2015 | 86 | 0.530 |
Why?
|
| Disease Models, Animal | 19 | 2019 | 7381 | 0.520 |
Why?
|
| Metals, Heavy | 1 | 2015 | 30 | 0.500 |
Why?
|
| Animals | 70 | 2024 | 61956 | 0.500 |
Why?
|
| Maternal Exposure | 3 | 2013 | 154 | 0.500 |
Why?
|
| Risperidone | 1 | 2015 | 62 | 0.490 |
Why?
|
| Folate Receptor 1 | 6 | 2024 | 61 | 0.480 |
Why?
|
| Anti-Anxiety Agents | 1 | 2015 | 100 | 0.480 |
Why?
|
| Benzodiazepines | 1 | 2015 | 167 | 0.460 |
Why?
|
| Arsenic Poisoning | 1 | 2013 | 6 | 0.460 |
Why?
|
| Behavior, Animal | 4 | 2015 | 747 | 0.440 |
Why?
|
| Seizures | 9 | 2017 | 1001 | 0.430 |
Why?
|
| Autistic Disorder | 1 | 2015 | 354 | 0.400 |
Why?
|
| Neurulation | 3 | 2024 | 24 | 0.400 |
Why?
|
| Cilia | 3 | 2024 | 90 | 0.390 |
Why?
|
| Bipolar Disorder | 1 | 2015 | 358 | 0.390 |
Why?
|
| Gene Expression Regulation, Developmental | 9 | 2024 | 1503 | 0.390 |
Why?
|
| Mice, Knockout | 21 | 2024 | 5728 | 0.380 |
Why?
|
| Carrier Proteins | 10 | 2007 | 2098 | 0.380 |
Why?
|
| Antipsychotic Agents | 1 | 2015 | 429 | 0.370 |
Why?
|
| Paired Box Transcription Factors | 3 | 2012 | 128 | 0.370 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 1024 | 0.360 |
Why?
|
| Tacrolimus Binding Proteins | 3 | 2020 | 81 | 0.350 |
Why?
|
| Pregnancy Outcome | 3 | 2012 | 684 | 0.340 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2024 | 485 | 0.310 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 1441 | 0.300 |
Why?
|
| Cyclopropanes | 4 | 2010 | 90 | 0.300 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2024 | 1281 | 0.290 |
Why?
|
| Female | 52 | 2024 | 148940 | 0.290 |
Why?
|
| Hedgehog Proteins | 5 | 2024 | 440 | 0.280 |
Why?
|
| Urea | 4 | 2009 | 304 | 0.270 |
Why?
|
| Mutation | 5 | 2024 | 15912 | 0.270 |
Why?
|
| Embryonic Development | 4 | 2009 | 310 | 0.260 |
Why?
|
| Carbamates | 2 | 2017 | 81 | 0.260 |
Why?
|
| Micronutrients | 1 | 2005 | 74 | 0.250 |
Why?
|
| Rats | 19 | 2017 | 6441 | 0.250 |
Why?
|
| Arsenic | 1 | 2006 | 49 | 0.250 |
Why?
|
| Membrane Transport Proteins | 3 | 2018 | 247 | 0.230 |
Why?
|
| Folate Receptors, GPI-Anchored | 10 | 2007 | 58 | 0.230 |
Why?
|
| Oxazines | 1 | 2024 | 41 | 0.230 |
Why?
|
| Dose-Response Relationship, Drug | 11 | 2017 | 5056 | 0.230 |
Why?
|
| Rhombencephalon | 1 | 2024 | 52 | 0.230 |
Why?
|
| Amniotic Fluid | 1 | 2024 | 154 | 0.220 |
Why?
|
| Repressor Proteins | 2 | 2022 | 1718 | 0.220 |
Why?
|
| Embryo Loss | 3 | 2013 | 39 | 0.220 |
Why?
|
| Gene Expression Profiling | 5 | 2019 | 5149 | 0.220 |
Why?
|
| Formates | 2 | 2024 | 17 | 0.210 |
Why?
|
| Rats, Sprague-Dawley | 12 | 2017 | 2156 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 7 | 2015 | 7100 | 0.190 |
Why?
|
| Pyridones | 1 | 2024 | 360 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2020 | 5776 | 0.190 |
Why?
|
| PAX3 Transcription Factor | 3 | 2012 | 36 | 0.190 |
Why?
|
| Wnt3A Protein | 1 | 2020 | 25 | 0.180 |
Why?
|
| Tetrahydrofolates | 1 | 2020 | 20 | 0.180 |
Why?
|
| Epilepsy | 4 | 2014 | 931 | 0.180 |
Why?
|
| Homeodomain Proteins | 3 | 2020 | 1125 | 0.180 |
Why?
|
| Cerebrum | 1 | 2020 | 40 | 0.180 |
Why?
|
| Gene Expression | 3 | 2006 | 3640 | 0.170 |
Why?
|
| Citalopram | 1 | 2020 | 34 | 0.170 |
Why?
|
| Mice, Mutant Strains | 7 | 2013 | 655 | 0.170 |
Why?
|
| Paroxetine | 1 | 2020 | 36 | 0.170 |
Why?
|
| Embryo Culture Techniques | 1 | 2019 | 31 | 0.170 |
Why?
|
| Mice, Inbred ICR | 1 | 2020 | 244 | 0.170 |
Why?
|
| Fetal Resorption | 2 | 2013 | 9 | 0.170 |
Why?
|
| Loss of Function Mutation | 1 | 2020 | 165 | 0.170 |
Why?
|
| Structure-Activity Relationship | 8 | 2017 | 979 | 0.170 |
Why?
|
| Tomography, Optical Coherence | 1 | 2024 | 550 | 0.160 |
Why?
|
| Neural Crest | 2 | 2013 | 85 | 0.160 |
Why?
|
| Microarray Analysis | 2 | 2012 | 396 | 0.160 |
Why?
|
| Toxicity Tests | 1 | 2018 | 50 | 0.160 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2018 | 46 | 0.160 |
Why?
|
| Embryonic and Fetal Development | 7 | 2004 | 227 | 0.150 |
Why?
|
| Fetal Death | 1 | 2018 | 134 | 0.150 |
Why?
|
| Signal Transduction | 6 | 2024 | 12103 | 0.150 |
Why?
|
| Embryo, Nonmammalian | 1 | 2018 | 245 | 0.150 |
Why?
|
| Homocysteine | 2 | 2012 | 148 | 0.150 |
Why?
|
| Sulfanilamides | 1 | 2017 | 4 | 0.140 |
Why?
|
| Carbonic Anhydrases | 1 | 2017 | 50 | 0.140 |
Why?
|
| Pentylenetetrazole | 6 | 2014 | 30 | 0.140 |
Why?
|
| Carboxylic Acids | 1 | 2017 | 57 | 0.140 |
Why?
|
| Genes, cdc | 1 | 1996 | 84 | 0.140 |
Why?
|
| Meningomyelocele | 1 | 2019 | 210 | 0.140 |
Why?
|
| Teratoma | 1 | 2018 | 248 | 0.130 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 517 | 0.130 |
Why?
|
| Craniofacial Abnormalities | 3 | 2013 | 250 | 0.130 |
Why?
|
| Crosses, Genetic | 2 | 2013 | 252 | 0.130 |
Why?
|
| Cytoskeletal Proteins | 5 | 2024 | 522 | 0.130 |
Why?
|
| Cell Polarity | 2 | 2024 | 212 | 0.130 |
Why?
|
| Zebrafish | 1 | 2018 | 457 | 0.130 |
Why?
|
| Kindling, Neurologic | 3 | 2017 | 15 | 0.130 |
Why?
|
| Fetoscopy | 1 | 2019 | 411 | 0.120 |
Why?
|
| Piperazines | 1 | 2024 | 2145 | 0.120 |
Why?
|
| Status Epilepticus | 2 | 2013 | 149 | 0.120 |
Why?
|
| Fetus | 1 | 2018 | 674 | 0.120 |
Why?
|
| Cricetinae | 4 | 2011 | 769 | 0.120 |
Why?
|
| Random Allocation | 2 | 2013 | 741 | 0.120 |
Why?
|
| Stereoisomerism | 5 | 2013 | 176 | 0.120 |
Why?
|
| Male | 27 | 2020 | 128315 | 0.120 |
Why?
|
| Homozygote | 2 | 2013 | 772 | 0.110 |
Why?
|
| Orofaciodigital Syndromes | 1 | 2013 | 7 | 0.110 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2013 | 22 | 0.110 |
Why?
|
| Ciliary Motility Disorders | 1 | 2013 | 14 | 0.110 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2013 | 13 | 0.110 |
Why?
|
| Sulfathiazoles | 1 | 2012 | 2 | 0.110 |
Why?
|
| Morphogenesis | 2 | 2013 | 319 | 0.110 |
Why?
|
| Pregnancy, Animal | 2 | 2007 | 102 | 0.110 |
Why?
|
| Mice, Inbred Strains | 8 | 2009 | 563 | 0.110 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2013 | 53 | 0.100 |
Why?
|
| Dietary Supplements | 1 | 2017 | 562 | 0.100 |
Why?
|
| Acetamides | 1 | 2013 | 111 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2017 | 497 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 1 | 2013 | 193 | 0.100 |
Why?
|
| Heterozygote | 2 | 2013 | 1056 | 0.100 |
Why?
|
| Central Nervous System Diseases | 1 | 2013 | 134 | 0.100 |
Why?
|
| Electroshock | 4 | 2014 | 47 | 0.100 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2012 | 40 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 4223 | 0.100 |
Why?
|
| Dronabinol | 1 | 2012 | 41 | 0.100 |
Why?
|
| Fetal Growth Retardation | 1 | 2013 | 232 | 0.100 |
Why?
|
| Embryo Implantation | 1 | 2013 | 289 | 0.100 |
Why?
|
| Heart | 3 | 2007 | 1195 | 0.100 |
Why?
|
| Facial Bones | 1 | 2011 | 46 | 0.100 |
Why?
|
| HIV Infections | 1 | 2024 | 2154 | 0.100 |
Why?
|
| Genotype | 3 | 2012 | 4252 | 0.090 |
Why?
|
| Humans | 22 | 2024 | 270740 | 0.090 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 453 | 0.090 |
Why?
|
| Congenital Abnormalities | 1 | 2013 | 280 | 0.090 |
Why?
|
| NIH 3T3 Cells | 2 | 2022 | 255 | 0.090 |
Why?
|
| Hair Follicle | 1 | 2010 | 63 | 0.090 |
Why?
|
| Analgesics | 2 | 2010 | 408 | 0.090 |
Why?
|
| Neurogenesis | 1 | 2012 | 241 | 0.080 |
Why?
|
| Skull | 1 | 2011 | 251 | 0.080 |
Why?
|
| Environmental Exposure | 1 | 2011 | 290 | 0.080 |
Why?
|
| Transcription Factors | 3 | 2020 | 5438 | 0.080 |
Why?
|
| Glucose Intolerance | 1 | 2009 | 86 | 0.080 |
Why?
|
| Convulsants | 3 | 2014 | 24 | 0.080 |
Why?
|
| Cell Differentiation | 3 | 2024 | 4116 | 0.080 |
Why?
|
| In Situ Hybridization | 2 | 2011 | 1049 | 0.080 |
Why?
|
| Biological Transport | 2 | 2006 | 626 | 0.070 |
Why?
|
| Anilides | 1 | 2010 | 295 | 0.070 |
Why?
|
| Body Patterning | 1 | 2007 | 208 | 0.070 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2007 | 54 | 0.070 |
Why?
|
| Transcription, Genetic | 3 | 2012 | 3339 | 0.070 |
Why?
|
| RNA, Messenger | 5 | 2013 | 6390 | 0.070 |
Why?
|
| Ephrins | 1 | 2006 | 11 | 0.070 |
Why?
|
| Inositol | 1 | 2006 | 27 | 0.070 |
Why?
|
| Methylcholanthrene | 1 | 2006 | 32 | 0.070 |
Why?
|
| Apoptosis | 3 | 2020 | 7757 | 0.070 |
Why?
|
| Wnt Signaling Pathway | 2 | 2024 | 444 | 0.070 |
Why?
|
| Biological Transport, Active | 2 | 2018 | 129 | 0.070 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2006 | 154 | 0.060 |
Why?
|
| Nervous System | 2 | 2004 | 183 | 0.060 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2006 | 79 | 0.060 |
Why?
|
| beta-Arrestin 2 | 1 | 2024 | 15 | 0.060 |
Why?
|
| Mutagenesis | 1 | 2006 | 518 | 0.060 |
Why?
|
| Diet | 1 | 2012 | 1477 | 0.060 |
Why?
|
| Formate-Tetrahydrofolate Ligase | 1 | 2024 | 3 | 0.060 |
Why?
|
| Soman | 2 | 2014 | 6 | 0.060 |
Why?
|
| Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 2024 | 10 | 0.060 |
Why?
|
| Heart Defects, Congenital | 2 | 2007 | 1795 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2009 | 1269 | 0.060 |
Why?
|
| Ganglia | 1 | 2024 | 25 | 0.060 |
Why?
|
| Epistasis, Genetic | 1 | 2024 | 120 | 0.060 |
Why?
|
| Cranial Nerves | 1 | 2024 | 28 | 0.060 |
Why?
|
| Isomerism | 2 | 2015 | 66 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 3597 | 0.050 |
Why?
|
| Biomechanical Phenomena | 1 | 2024 | 279 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2009 | 1023 | 0.050 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2024 | 153 | 0.050 |
Why?
|
| Rats, Wistar | 2 | 2001 | 598 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 2351 | 0.050 |
Why?
|
| Hippocampus | 1 | 2008 | 919 | 0.050 |
Why?
|
| Cacodylic Acid | 1 | 2001 | 9 | 0.050 |
Why?
|
| Growth Substances | 2 | 2000 | 326 | 0.050 |
Why?
|
| Arsenites | 1 | 2001 | 20 | 0.050 |
Why?
|
| Exosomes | 1 | 2024 | 255 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2024 | 659 | 0.050 |
Why?
|
| Cadmium Chloride | 1 | 2001 | 5 | 0.050 |
Why?
|
| Penicillin G | 1 | 2001 | 20 | 0.050 |
Why?
|
| Amino Acids | 2 | 2017 | 783 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2001 | 143 | 0.050 |
Why?
|
| Estrogen Receptor alpha | 1 | 2006 | 692 | 0.050 |
Why?
|
| Diethylstilbestrol | 1 | 2001 | 165 | 0.050 |
Why?
|
| Mesocricetus | 1 | 2001 | 119 | 0.050 |
Why?
|
| Organ Size | 3 | 2008 | 692 | 0.050 |
Why?
|
| Arsenicals | 1 | 2001 | 205 | 0.050 |
Why?
|
| Actins | 1 | 2024 | 602 | 0.050 |
Why?
|
| Neuroaxonal Dystrophies | 1 | 2020 | 13 | 0.050 |
Why?
|
| Sulfonamides | 1 | 2010 | 1933 | 0.050 |
Why?
|
| Polyunsaturated Alkamides | 2 | 2012 | 41 | 0.040 |
Why?
|
| Nerve Growth Factors | 1 | 2000 | 128 | 0.040 |
Why?
|
| Dioxolanes | 1 | 1999 | 51 | 0.040 |
Why?
|
| Nervous System Malformations | 1 | 2020 | 135 | 0.040 |
Why?
|
| Protein Transport | 2 | 2013 | 737 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2022 | 1685 | 0.040 |
Why?
|
| Sheep | 1 | 2019 | 275 | 0.040 |
Why?
|
| Phenytoin | 1 | 1999 | 81 | 0.040 |
Why?
|
| Half-Life | 2 | 2009 | 269 | 0.040 |
Why?
|
| Phenotype | 3 | 2019 | 6509 | 0.040 |
Why?
|
| Genes, Dominant | 1 | 2019 | 356 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2011 | 507 | 0.040 |
Why?
|
| Cell Line | 2 | 2018 | 5338 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2024 | 1654 | 0.040 |
Why?
|
| Carbamazepine | 1 | 1996 | 55 | 0.030 |
Why?
|
| Fetal Weight | 2 | 2008 | 53 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2022 | 1192 | 0.030 |
Why?
|
| Wnt Proteins | 1 | 2019 | 384 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2020 | 5694 | 0.030 |
Why?
|
| Penetrance | 1 | 2017 | 134 | 0.030 |
Why?
|
| Age Factors | 1 | 2006 | 5457 | 0.030 |
Why?
|
| Administration, Oral | 3 | 2008 | 1608 | 0.030 |
Why?
|
| Carnitine | 1 | 2017 | 89 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2020 | 8699 | 0.030 |
Why?
|
| Genetic Techniques | 1 | 1997 | 152 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2020 | 1461 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 2042 | 0.030 |
Why?
|
| Models, Animal | 2 | 2010 | 657 | 0.030 |
Why?
|
| Purines | 1 | 2017 | 271 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2020 | 2090 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2014 | 95 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 2 | 2006 | 208 | 0.030 |
Why?
|
| Metabolome | 1 | 2017 | 355 | 0.030 |
Why?
|
| Palate | 1 | 2013 | 24 | 0.030 |
Why?
|
| Complement C5 | 1 | 2013 | 15 | 0.030 |
Why?
|
| Bardet-Biedl Syndrome | 1 | 2013 | 38 | 0.030 |
Why?
|
| Uronic Acids | 1 | 1993 | 7 | 0.030 |
Why?
|
| Humic Substances | 1 | 1993 | 2 | 0.030 |
Why?
|
| Analysis of Variance | 3 | 2006 | 2315 | 0.030 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2013 | 115 | 0.030 |
Why?
|
| Lipids | 1 | 2017 | 654 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2014 | 729 | 0.030 |
Why?
|
| Carbohydrates | 1 | 1993 | 55 | 0.030 |
Why?
|
| Maxilla | 1 | 2013 | 89 | 0.030 |
Why?
|
| Vitamin B 12 | 1 | 2013 | 76 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 2573 | 0.030 |
Why?
|
| Risk Factors | 2 | 2020 | 17888 | 0.030 |
Why?
|
| Cannabinoid Receptor Modulators | 1 | 2012 | 7 | 0.030 |
Why?
|
| Glycerides | 1 | 2012 | 11 | 0.030 |
Why?
|
| Body Weight | 2 | 2008 | 1307 | 0.030 |
Why?
|
| Arachidonic Acids | 1 | 2012 | 34 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2014 | 451 | 0.030 |
Why?
|
| Prosencephalon | 1 | 2012 | 49 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 3063 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2002 | 2765 | 0.020 |
Why?
|
| Endocannabinoids | 1 | 2012 | 26 | 0.020 |
Why?
|
| Pain | 2 | 2010 | 1694 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2012 | 220 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2007 | 2471 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 277 | 0.020 |
Why?
|
| Telomerase | 2 | 2005 | 547 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2012 | 179 | 0.020 |
Why?
|
| CHO Cells | 1 | 2011 | 320 | 0.020 |
Why?
|
| Dermis | 1 | 2010 | 63 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2012 | 354 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2018 | 7238 | 0.020 |
Why?
|
| Mouth Abnormalities | 1 | 2010 | 16 | 0.020 |
Why?
|
| Epidermis | 1 | 2010 | 196 | 0.020 |
Why?
|
| Pentanoic Acids | 1 | 2009 | 3 | 0.020 |
Why?
|
| Touch | 1 | 2010 | 69 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 722 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 1121 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2019 | 6224 | 0.020 |
Why?
|
| Hypospadias | 1 | 2010 | 82 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2009 | 338 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2009 | 214 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 1997 | 2115 | 0.020 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2007 | 19 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 1199 | 0.020 |
Why?
|
| Cell Communication | 1 | 2010 | 512 | 0.020 |
Why?
|
| beta Catenin | 1 | 2011 | 683 | 0.020 |
Why?
|
| Electrodes, Implanted | 1 | 2008 | 185 | 0.020 |
Why?
|
| Epithelium | 1 | 2009 | 782 | 0.020 |
Why?
|
| Rotarod Performance Test | 1 | 2006 | 24 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 2012 | 547 | 0.020 |
Why?
|
| Fetal Development | 1 | 2008 | 118 | 0.020 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2006 | 9 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2010 | 401 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 1472 | 0.020 |
Why?
|
| Leucovorin | 1 | 2007 | 345 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2006 | 329 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2010 | 1016 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 1997 | 3438 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2006 | 92 | 0.020 |
Why?
|
| Cell Movement | 1 | 2013 | 2472 | 0.020 |
Why?
|
| Dimerization | 1 | 2006 | 311 | 0.020 |
Why?
|
| No-Observed-Adverse-Effect Level | 1 | 2005 | 6 | 0.020 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2005 | 23 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2006 | 398 | 0.020 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2005 | 95 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2005 | 129 | 0.020 |
Why?
|
| Reduced Folate Carrier Protein | 1 | 2005 | 20 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 3476 | 0.020 |
Why?
|
| Skin | 1 | 2010 | 1271 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2006 | 436 | 0.020 |
Why?
|
| Chimera | 1 | 2005 | 152 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2006 | 572 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2009 | 1741 | 0.010 |
Why?
|
| Species Specificity | 1 | 2006 | 794 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2005 | 374 | 0.010 |
Why?
|
| Gestational Age | 2 | 2000 | 1173 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2017 | 3669 | 0.010 |
Why?
|
| Chromosomal Instability | 1 | 2005 | 229 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2005 | 474 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2006 | 589 | 0.010 |
Why?
|
| Ligands | 1 | 2006 | 1012 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2004 | 632 | 0.010 |
Why?
|
| Insulin | 1 | 2009 | 1483 | 0.010 |
Why?
|
| Computational Biology | 1 | 2009 | 1291 | 0.010 |
Why?
|
| Reproduction | 1 | 2005 | 278 | 0.010 |
Why?
|
| Multigene Family | 1 | 2004 | 469 | 0.010 |
Why?
|
| Cell Cycle | 2 | 2000 | 2137 | 0.010 |
Why?
|
| Caspases | 1 | 2005 | 679 | 0.010 |
Why?
|
| Motor Activity | 1 | 2006 | 699 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2006 | 1356 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2006 | 623 | 0.010 |
Why?
|
| Estradiol | 1 | 2006 | 827 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2003 | 526 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2005 | 1810 | 0.010 |
Why?
|
| Kidney | 1 | 2010 | 2121 | 0.010 |
Why?
|
| Myocardium | 1 | 2007 | 1232 | 0.010 |
Why?
|
| Radiation Hybrid Mapping | 1 | 2000 | 11 | 0.010 |
Why?
|
| Lod Score | 1 | 2000 | 173 | 0.010 |
Why?
|
| Uterus | 1 | 2006 | 798 | 0.010 |
Why?
|
| Transfection | 1 | 2006 | 3117 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2000 | 188 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2000 | 192 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 2657 | 0.010 |
Why?
|
| Brain | 1 | 2013 | 4208 | 0.010 |
Why?
|
| DNA Fingerprinting | 1 | 2000 | 180 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1999 | 124 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 704 | 0.010 |
Why?
|
| NADP | 1 | 1999 | 88 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2000 | 876 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 1542 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 1430 | 0.010 |
Why?
|
| Phylogeny | 1 | 2000 | 867 | 0.010 |
Why?
|
| Liver | 1 | 2008 | 3086 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 1581 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1999 | 737 | 0.010 |
Why?
|
| Genes, fos | 1 | 1997 | 55 | 0.010 |
Why?
|
| RNA, Antisense | 1 | 1997 | 78 | 0.010 |
Why?
|
| Genes, bcl-2 | 1 | 1997 | 172 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1997 | 938 | 0.010 |
Why?
|
| Neurons | 1 | 2006 | 2439 | 0.010 |
Why?
|
| Hyperthermia, Induced | 1 | 2000 | 511 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2000 | 4567 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2000 | 6685 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1999 | 3530 | 0.010 |
Why?
|
| Soil | 1 | 1993 | 59 | 0.010 |
Why?
|
| Genes, p53 | 1 | 1997 | 1140 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 1997 | 1109 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 5002 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1993 | 633 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 14849 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1997 | 1838 | 0.010 |
Why?
|
| Time Factors | 1 | 1998 | 13006 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 16215 | 0.000 |
Why?
|